EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of cerebrospinal fluid (CSF) and interstitial fluid (ISF) mouse proteomes for the validation and description of Alzheimer’s disease biomarkers

Anna Maria Górska, Irene Santos-García, Ivan Eiriz, Thomas Brüning, Tuula Nyman, Jens Pahnke

Journal of Neuroscience Methods · 2024

DOI: 10.1016/j.jneumeth.2024.110239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroscience Methods, 2024. Verfasst von Anna Maria Górska und 5 weiteren Autor:innen. Beteiligte Einrichtung: Translational Neurodegeneration Research and Neuropathology Lab, Department of Clinical Medicine (KlinMed), Medical Faculty, University of Oslo (UiO)…. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Extracellular Fluid, Mice, Inbred C57BL. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Technology Agency of the Czech Republic, Latvian Council of Sciences, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mass spectrometry (MS)-based cerebrospinal fluid (CSF) proteomics is an important method for discovering biomarkers of neurodegenerative diseases. CSF serves as a reservoir for interstitial fluid (ISF), and extensive communication between the two fluid compartments helps to remove waste products from the brain. NEW METHOD: We performed proteomic analyses of both CSF and ISF fluid compartments using intracerebral microdialysis to validate and detect novel biomarkers of Alzheimer's disease (AD) in APPtg and C57Bl/6J control mice. RESULTS: We identified up to 625 proteins in ISF and 4483 proteins in CSF samples. By comparing the biofluid profiles of APPtg and C57Bl/6J mice, we detected 37 and 108 significantly up- and downregulated candidates, respectively. In ISF, 7 highly regulated proteins, such as Gfap, Aldh1l1, Gstm1, and Txn, have already been implicated in AD progression, whereas in CSF, 9 out of 14 highly regulated proteins, such as Apba2, Syt12, Pgs1 and Vsnl1, have also been validated to be involved in AD pathogenesis. In addition, we also detected new interesting regulated proteins related to the control of synapses and neurotransmission (Kcna2, Cacng3, and Clcn6) whose roles as AD biomarkers should be further investigated. COMPARISON WITH EXISTING METHODS: This newly established combined protocol provides better insight into the mutual communication between ISF and CSF as an analysis of tissue or CSF compartments alone. CONCLUSIONS: The use of multiple fluid compartments, ISF and CSF, for the detection of their biological communication enables better detection of new promising AD biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiomarkersExtracellular FluidMice, Inbred C57BLProteomeMice, TransgenicAnimalsMiceProteomicsDisease Models, AnimalMicrodialysisAmyloid beta-Protein PrecursorMale

Stichwörter der Autor:innen

Alzheimer’s diseaseBiomarkersBrain fluidsCSFExpression profilesISFMass spectrometryMicrodialysisNeurodegenerationProtein identificationProteomics

Substanzen

BiomarkersProteomeAmyloid beta-Protein Precursor

Autor:innen und Institutionen

  • Translational Neurodegeneration Research and Neuropathology Lab, Department of Clinical Medicine (KlinMed), Medical Faculty, University of Oslo (UiO) and Section of Neuropathology Research, Department of Pathology, Clin…
  • Proteomics Core Facility, Department of Immunology, Oslo University Hospital (OUS) and University of Oslo (UiO), Faculty of Medicine, Sognsvannsveien 20, Oslo NO-0372, Norway. Electronic address: tuula.nyman@medisin.uio…

Förderung

  • Technology Agency of the Czech Republic
  • Latvian Council of Sciences
  • Deutsche Forschungsgemeinschaft
  • Helse Sør-Øst RHF
  • Norges forskningsråd
  • Barnekreftforeningen
  • Bundesministerium fur Bildung und Forschung Dienststelle Bonn

Zitieren

APA

Górska, A. M., Santos-García, I., Eiriz, I., Brüning, T., Nyman, T., & Pahnke, J. (2024). Evaluation of cerebrospinal fluid (CSF) and interstitial fluid (ISF) mouse proteomes for the validation and description of Alzheimer’s disease biomarkers. Journal of Neuroscience Methods. https://doi.org/10.1016/j.jneumeth.2024.110239

Vancouver

Górska AM, Santos-García I, Eiriz I, Brüning T, Nyman T, Pahnke J. Evaluation of cerebrospinal fluid (CSF) and interstitial fluid (ISF) mouse proteomes for the validation and description of Alzheimer’s disease biomarkers. Journal of Neuroscience Methods. 2024. doi:10.1016/j.jneumeth.2024.110239

BibTeX
@article{Grska2024,
  author = {Górska, Anna Maria and Santos-García, Irene and Eiriz, Ivan and Brüning, Thomas and Nyman, Tuula and Pahnke, Jens},
  title = {Evaluation of cerebrospinal fluid (CSF) and interstitial fluid (ISF) mouse proteomes for the validation and description of Alzheimer’s disease biomarkers},
  journal = {Journal of Neuroscience Methods},
  year = {2024},
  doi = {10.1016/j.jneumeth.2024.110239}
}
Kostenlos starten →